patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
belumosudil mesylate
Marketedupdated 2mo agoby Kadmon Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(5)
approval · 5
Jul 16, 2021
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Nov 9, 2023
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Apr 10, 2024
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Dec 30, 2024
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Jan 15, 2026
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that